Playbooks, reviewer perspectives, templates and demos.
One working knowledge hub, articles, guides, templates, videos and use case demos. Looking for definitions? Browse the glossary →
Investor narrative one-pager
A one-pager deck template for investor and BD conversations — anchored in HTA precedent, comparator landscape, pricing corridor and BD comparables.
The investor-ready narrative: Series C in one deck
The Series C deck is not a science talk. It is a sequencing argument. Here is the eight-slide spine the strongest decks share — and the numbers behind each one.
Launch readiness
A continuously refreshed launch-readiness map — competitor pipeline, HTA precedent, payer mix, KOLs, RWE and field readiness.
Competitive intelligence
A continuously refreshed view of every competitor — pipeline, readouts, label changes, HTA decisions, KOL voice and pricing trajectory.
Investor narrative
Build the value narrative on the same evidence base your CMO uses for the dossier — defensible, comparable-anchored, ready for diligence.
BD & licensing diligence
Map the target's clinical position, competitor landscape, HTA precedent, pricing corridor and deal comparables in one workspace.
Pipeline prioritisation
Score every asset and indication against competitor pipeline, HTA precedent, addressable population and pricing corridor.
Pricing corridors for ultra-orphans in 2026
Why ultra-orphan pricing corridors are tightening in 2026 — IRP knock-ons, post-JCA national flexibility, and how to set a launch price that still defends the asset in year three.
ArticleProfit is hiding in your process: The three biggest efficiency leaks in your consulting workflow
If you’ve been in market access consulting long enough, you know this truth: great people can’t overcome broken systems forever.
ArticleThe silent squeeze: How pharma’s ‘do more with less’ culture is reshaping the consultancy business model
Pharma is under pressure. Their answer? Push more work downstream, demand it faster, and expect the same (or higher) standard for less.
ArticleConsultancy burnout is a system problem, not a people problem
In consulting, there’s a long-standing myth: the best people are the ones who can take on more. More timelines. More fire drills. More deliverables.
ArticleEvery proposal is a bet: Why consultancies can’t afford to lose time on speculative work
Most market access firms underestimate the resource drain of speculative work. A typical proposal isn’t just a quote and a few paragraphs. It’s a crafted narrative. A mini-strategy.
ArticleThe hidden cost of rework: Why knowledge loss is killing profitability in market access consulting
Most consultancies don’t realise how much time they’re losing to rework, because it doesn’t show up on a single line in the P&L.
ArticleWhy market access consulting is now a three-dimensional challenge, and what to do about it
Once upon a time, market access consulting was tough but manageable. Now it’s become a three-dimensional challenge and every axis is working against you.
Plain-English definitions for AMNOG, ICER, JCA, ITC/MAIC, RWE and the rest of the vocabulary teams actually use.